Journal of Pharmacovigilance & Drug Safety

Skip to main content Skip to main navigation menu Skip to site footer

Announcements

Homepage

2022-12-08

Welcome to the Journal of Pharmacovigilance & Drug Safety (JPDS).

Journal of Pharmacovigilance & Drug Safety is a peer-reviewed open-access international medical research journal that publishes original research work in the form of Full Length Papers, Review Articles, Case Reports, Letter to Editor, Short communications, Drug Updates. The journal is printed Two times a year. The language of the journal is English.

The journal is available online since 2019.

Subject/Areas of Publication:

Journal of Pharmacovigilance & Drug Safety (JPDS) is the official journal of the Society of Pharmacovigilance India. The journal includes all the articles related to Medical Sciences especially:

Pharmacovigilance signal
Pharmacovigilance Data Management
Adverse Drug Reaction
Adverse Events
Risk assessment and management
Drug Informatics
Epidemiological Methods
Clinical drug manifestations of adverse drug reactions
Post marketing surveillance
Medical evaluation of adverse events
Pharmacogenetics
Pharmacogenomics
Materiovigilance
Evopharmacovigilance
Herbal drugs safety

Read more about Homepage

Current Issue

Vol 20 No 1 (2023): Volume 20| Issue 1| January - June 2023

Published: 2023-07-28

REVIEW ARTICLES

Need of Pharmacovigilance in Siddha System of Medicine

A.Alif Fathima, M P Abdul Kader Jeylani, S. Balamani, U. Kavitha

1-5
- PDF

ORIGINAL ARTICLES

Level of hepatic enzymes and serum zinc and copper at start of Anti-tubercular treatment (ATT) and a onset of hepatitis induced by ATT

Anil Kumar, Mahima Singh, K.C. Singhal, A K Bansal

6-9
- PDF
A Study on Patients Drop-Out in Unani Pharmacopeial Validation of An Anti-obesity Drug

Misbahuddin Azhar, Rashidul Islam Ansari, Sadia Ayub, Nighat Anjum, Anirban Rej

10-15
- PDF
Community pharmacy staff’s barriers and factors motivating to report adverse drug reactions: A prospective, cross-sectional study in Tamil Nadu

S Darshna, MG Rajanandh

16-19
- PDF

CASE REPORT

A Case Report of Cisplatin Induced Ototoxicity and Brief Review of Literature

Ahmad Najmi, Ratinder Jhaj, S. Balakrishnan, Deepa Chaudhary

20-22
- PDF

ABSTRACTS

SoPICON 2023' & Medication Safety in an Era Of Evidence-Based Medicine held at AIIMS Rishikesh

sopi sopi

23-47
- PDF

View All Issues

In the modern era of clinical application of knowledge of pharmacology, it is a big dilemma in hoosing between the good and the best drug. In making a decision for treatment planning clinician must consider the additional features of local and systemic issues, patient's economic status as well as potential adverse effect of the drug.

There are large number of drug trial going on world wide to observe the effect of a particular drug or a molecule. However, the scenario has changed drastically in last 20 years. What it was with the western/ developed world is now shifting over to developing world.

India is set to grab clinical trial business, making the subcontinent world's preferred destination for clinical trials. The big reason being low cost of trial along with friendly drug control system with competent work force and patient availability. Indian investigators and clinical trial research professionals have already demonstrated their medical and scientific skills in various global clinical trials. It is time now to capitalize on this opportunity. Indian investigators and research professionals can prove their ability and show to the world and register their presence now as well as for future.